Sep 17 FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes By Matthew Perrone, Associated Press The Food and Drug Administration on Tuesday posted more than 100 letters to various drugmakers and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered around lower-cost versions of blockbuster obesity injections. Continue reading
Jul 28 In the gray world of GLP-1 supplements online, health experts urge caution By Hannah Grabenstein Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, which can be deceptive. Continue reading